Study of Efficacy and Safety of Erenumab in Adult Chronic Migraine Patients
NCT03867201
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
557
Enrollment
INDUSTRY
Sponsor class
Conditions
Migraine
Interventions
BIOLOGICAL:
Erenumab
OTHER:
Placebo
Sponsor
Novartis Pharmaceuticals